These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2566209)

  • 1. Peripheral blood stem cell collection and use in Hodgkin's disease. Comparison with marrow in autologous transplantation.
    Lasky LC; Hurd DD; Smith JA; Haake R
    Transfusion; 1989 May; 29(4):323-7. PubMed ID: 2566209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: a prospective, comparative trial.
    Weisdorf DJ; Verfaille CM; Miller WJ; Blazar BR; Perry E; Shu XO; Daniels K; Hannan P; Ramsay NK; Kersey JH; McGlave PB
    Am J Hematol; 1997 Mar; 54(3):202-8. PubMed ID: 9067498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease.
    Phillips GL; Reece DE; Lerner KG; Connors JM
    Bone Marrow Transplant; 1990 Jul; 6(1):45-7. PubMed ID: 1975204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prompt engraftment using autologous peripheral blood stem cells for double autologous bone marrow rescue.
    Hillyer CD; Comenzo RL; Miller KB; Schenkein DP; Tiegerman KO; Fogaren TA; Wazer DE; Parker L; Abrams RA; Desforges JF
    Am J Hematol; 1991 Feb; 36(2):152-3. PubMed ID: 2012067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
    Langenmayer I; Weaver C; Buckner CD; Lilleby K; Appelbaum FR; Longin K; Rowley S; Storb R; Singer J; Bensinger WI
    Bone Marrow Transplant; 1995 Feb; 15(2):241-6. PubMed ID: 7773213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood and bone marrow hematopoietic stem cells: are they the same?
    Janssen WE
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):19-27. PubMed ID: 8211212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cell transfusion for marrow replacement.
    Morse EE; Dainiak N; Sorba S; King C; Gaffney J; Ascensao JL
    Ann Clin Lab Sci; 1992; 22(4):221-5. PubMed ID: 1380224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide mobilization of peripheral blood stem cells for use in autologous transplantation after high-dose chemotherapy: clinical results in patients with contaminated or hypocellular bone marrow.
    Myers SE; Williams SF; Geller RB
    J Hematother; 1992; 1(1):27-33. PubMed ID: 1365014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus.
    Wu FY; Heng KK; Salleh RB; Soh TG; Lee JJ; Mah J; Linn YC; Loh Y; Hwang W; Tan LK; Law P; Goh YT
    Transfus Apher Sci; 2012 Dec; 47(3):345-50. PubMed ID: 23032067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effectiveness of hematopoietic cell mobilization with chemotherapy and filgrastim versus filgrastim alone for autologous transplant in patients with lymphoma.].
    Gutiérrez-Aguirre CH; De la Garza-Salazar F; Cantú-Rodríguez O; González-Llano Ó; Jaime-Pérez JC; Mancias-Guerra C; García-Sepúlveda R; Salazar-Riojas R; Gómez-Almaguer D
    Gac Med Mex; 2016 Oct; 152(Suppl 2):57-65. PubMed ID: 27792717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center].
    Rio B; Marjanovic Z; Belhocine R; Vekhoff A; Andrieu V; Klaren J; Boccaccio C; Delmer A; Ajchenbaum-Cymbalista F; Hunault M; Bazarbachi A; Lévy V; Andreu G; Zittoun R
    Ann Med Interne (Paris); 1996; 147(5):313-9. PubMed ID: 9033732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
    J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
    Brunvand MW; Bensinger WI; Soll E; Weaver CH; Rowley SD; Appelbaum FR; Lilleby K; Clift RA; Gooley TA; Press OW; Fefer A; Storb R; Sanders JE; Martin PL; Chauncey T; Maziarz RT; Zuckerman N; Montgomery P; Dorn R; Weiden PL; Demirer T; Holmberg LA; Schiffman K; McSweeney PA; Buckner CD
    Bone Marrow Transplant; 1996 Jul; 18(1):131-41. PubMed ID: 8832006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
    Lobo F; Kessinger A; Landmark JD; Smith DM; Weisenburger DD; Wigton RS; Armitage JO
    Bone Marrow Transplant; 1991 Nov; 8(5):389-92. PubMed ID: 1685105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.